Clinical trial
COVID-19 Antibody Responses In Cystic Fibrosis: CAR-CF
NCT04863573 is registered in ClinicalTrials.gov with Queen's University, Belfast as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- COVID-19 Antibody Responses In Cystic Fibrosis: CAR-CF
- Lead sponsor
- Queen's University, Belfast
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- November 19, 2021
- Completion date
- August 31, 2027
- Enrollment
- 1,000 (estimated)
- Sites
- 11
Conditions
As the registry lists them; a condition with its own page is linked.
covid19, cystic fibrosis